Immune Design (IMDZ) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts IMDZ Hot Sheet
Join SI Premium – FREE
Immune Design (NASDAQ: IMDZ) reported Q2 EPS of ($0.54), $0.07 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASML Holdings (ASML) Tops Q2 EPS by 59c; offers guidance
- Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue
- Goldman Sachs (GS) PT Raised to $1,299 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
